Status:
TERMINATED
Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Cognitive Deterioration
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
All over the world the increasing prevalence of chronic disorders and its impact on functional decline is challenging the sustainability of health care systems. Older individuals also frequently exper...
Detailed Description
The non pharmacological therapeutic will be install at patient's home : * aromatherapy, * music therapy, * cognitive training in multimedia application offering cognitive games. Also smart phone wil...
Eligibility Criteria
Inclusion
- Male or female age ≥ 60 years with memory complaint
- Score at the Mini Mental Test (MMSE) ≥ 26.
- Score at the Clinical Dementia Rating Scale (CDR) ≤ 0.5.
Exclusion
- Sensory defect (visual or olfactory) preventing the patient to perfectly meet therapeutic solutions.
- Prescription new psychotropic medication (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week preceding the assessment.
- Subject epileptic.
- Subject vulnerable
Key Trial Info
Start Date :
June 4 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2017
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT02288221
Start Date
June 4 2015
End Date
July 5 2017
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Claude Pompidou
Nice, France, 06000